refractory Inflammatory Myofibroblastic Tumors (DBCOND0150134)
Identifiers
- Synonyms
- Not Available
Associated Data
- Indicated Drugs and Targets
Drug Description Targets Crizotinib A receptor tyrosine kinase inhibitor used to treat metastatic non-small cell lung cancer (NSCLC) where the tumors have been confirmed to be anaplastic lymphoma kinase (ALK), or ROS1-positive.- Cytochrome P450 3A4enzyme
- Cytochrome P450 3A5enzyme
- ATP-dependent translocase ABCB1transporter
- ALK tyrosine kinase receptortarget
- Hepatocyte growth factor receptortarget
- Cytochrome P450 2B6enzyme
- Cytochrome P450 3A Subfamilyenzyme
- Albumincarrier
- alpha1-acid glycoproteincarrier
- Proto-oncogene tyrosine-protein kinase ROStarget
- Macrophage-stimulating protein receptortarget
- Clinical Trials
- Not Available